Lin Mei

Prof. Dr. Lin Mei

Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in ACS Nano
Verified
Journal Article
Closed access
WCWei Cheng
Wei Cheng
Xiaowei ZengXiaowei Zeng
Xiaowei Zeng
HCHongzhong Chen
Hongzhong Chen
ZLZimu Li
Zimu Li
WZWenfeng Zeng
Wenfeng Zeng
YZYanli Zhao
Yanli Zhao

31 October 2016 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
WTWei Tao
Wei Tao
XZXianbing Zhu
Xianbing Zhu
XYXinghua Yu
Xinghua Yu
XZXiaowei Zeng
Xiaowei Zeng
QXQuanlan Xiao
Quanlan Xiao
Lin MeiLin Mei
Lin Mei

16 August 2018 in Advanced Science
Verified
Journal Article
Open access
PDF file
XZXiaowei Zeng
Xiaowei Zeng
MLMiaomiao Luo
Miaomiao Luo
GLGan Liu
Gan Liu
XWXusheng Wang
Xusheng Wang
WTWei Tao
Wei Tao
Lin MeiLin Mei
Lin Mei
As a novel 2D material, black phosphorus (BP) nanosheets are considered as a promising candidate for drug delivery platform for synergistic chemo/photothermal therapy. However, the intrinsic instability of bare BP poses a challenge in its biomedical applications. To date, some strategies have been employed to prevent BP from rapid ambient degradation. Unfortunately, most of these strategies are not suitable for the drug delivery systems. Here, a simple polydopamine modification method is developed to enhance the stability and photothermal performance of bare BP nanosheets. Then, this nanocapsule is used as a multifunctional codelivery system for the targeted chemo, gene, and photothermal therapy against multidrug‐resistant cancer. The enhanced tumor therapy effect is demonstrated by both in vitro and in vivo studies.

1 January 2014 in Theranostics
Verified
Journal Article
Open access
MMMadaswamy S. Muthu
Madaswamy S. Muthu
DLDavid Tai Leong
David Tai Leong
Lin MeiLin Mei
Lin Mei
SFSi-Shen Feng
Si-Shen Feng
Nanotheranostics is to apply and further develop nanomedicine strategies for advanced theranostics. This review summarizes the various nanocarriers developed so far in the literature for nanotheranostics, which include polymer conjugations, dendrimers, micelles, liposomes, metal and inorganic nanoparticles, carbon nanotubes, and nanoparticles of biodegradable polymers for sustained, controlled and targeted co-delivery of diagnostic and therapeutic agents for better theranostic effects with fewer side effects. The theranostic nanomedicine can achieve systemic circulation, evade host defenses and deliver the drug and diagnostic agents at the targeted site to diagnose and treat the disease at cellular and molecular level. The therapeutic and diagnostic agents are formulated in nanomedicine as a single theranostic platform, which can then be further conjugated to biological ligand for targeting. Nanotheranostics can also promote stimuli-responsive release, synergetic and combinatory therapy, siRNA co-delivery, multimodality therapies, oral delivery, delivery across the blood-brain barrier as well as escape from intracellular autophagy. The fruition of nanotheranostics will be able to provide personalized therapy with bright prognosis, which makes even the fatal diseases curable or at least treatable at the earliest stage.

4 February 2019 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
MLMiaomiao Luo
Miaomiao Luo
TFTaojian Fan
Taojian Fan
YZYun Zhou
Yun Zhou
HZHan Zhang
Han Zhang
Lin MeiLin Mei
Lin Mei

22 May 2017 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
WCWei Cheng
Wei Cheng
JNJunpeng Nie
Junpeng Nie
LXLv Xu
Lv Xu
CLChaoyu Liang
Chaoyu Liang
YPYunmei Peng
Yunmei Peng
Xiaowei ZengXiaowei Zeng
Xiaowei Zeng